Clinical trials in Vila Franca De Xira

8 clinical trials in Vila Franca De Xira, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PortugalEnsaios-Clinicos.pt

Vila Franca De Xira at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

8 trials in Vila Franca De Xira

Open in trial search

Cardiovascular disorder+2

Recruiting

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:BI 690517
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Arteriosclerosis

Recruiting

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Clazakizumab
Sponsor:CSL Behring LLC

Contact Research Centre

Type 2 diabetes mellitus

Not yet recruiting

Efficacy and Safety of Alogliptin Plus Empagliflozin Compared with Alogliptin Alone or Empagliflozin Alone in Adults with Type 2 Diabetes on Metformin

Registered drug

Efficacy and Safety of Alogliptin Plus Empagliflozin Compared with Alogliptin Alone or Empagliflozin Alone in Adults with Type 2 Diabetes on Metformin

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Alogliptin
Sponsor:Tecnimede-Sociedade Tecnico-Medicinal S.A.

Contact Research Centre

Pneumonia bacterial

Not yet recruiting

Safety and tolerability study of bacteriophage cocktail TP-122A given by inhalation in adults with ventilator-associated pneumonia

Investigational

Safety and tolerability study of bacteriophage cocktail TP-122A given by inhalation in adults with ventilator-associated pneumonia

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Demerecviridae bacteriophage against klebesiella pneumoniae (113.073 BP)
Sponsor:Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Salbutamol
Sponsor:AstraZeneca AB

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Salbutamol Sulfate
Sponsor:AstraZeneca AB

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Stemline Therapeutics Inc.

Contact Research Centre

Diabetic retinopathy+1

Not recruiting

Study on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease

Investigational

Study on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:BAY 3283142
Sponsor:Bayer AG

Contact Research Centre

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Vila Franca De Xira

What the registry says about research in the country

01 Oncology Research

Innovative clinical research focusing on breast cancer treatment, specifically targeting patients with node-positive, estrogen receptor-positive, HER2-negative early-stage disease. The trials aim to evaluate new endocrine therapy approaches for improving patient outcomes.

Early-stage breast cancer
Hormone receptor-positive disease
High-risk recurrence cases

Research explores novel therapeutic options to enhance survival rates in breast cancer patients.

02 Nephrology Studies

Comprehensive research into chronic kidney disease and related conditions, investigating innovative treatments for reducing protein excretion and improving kidney function. Multiple trials are examining novel therapeutic compounds.

Chronic kidney disease management
Focal segmental glomerulosclerosis
Protein excretion disorders

Studies focus on developing targeted treatments for various kidney disorders and their complications.

03 Cardiovascular-Renal Research

Advanced clinical trials investigating the intersection of cardiovascular disease and end-stage kidney disease. Research focuses on innovative treatments for patients undergoing dialysis, with particular attention to inflammatory markers.

Atherosclerotic cardiovascular disease
End-stage kidney disease
Dialysis-related complications

These studies aim to improve outcomes for patients with complex cardiovascular-renal conditions.

Back to Portugal All countries